Comparative impact of Roux-en-Y gastric bypass, sleeve gastrectomy or diet alone on beta-cell function in insulin-treated type 2 diabetes patients
Abstract Although bariatric surgery is an effective treatment for type 2 diabetes by inducing weight loss and augmenting gut hormone secretion, the immediate effect on beta-cell function itself remains to be elucidated in type 2 diabetes. Therefore, a prospective, randomized trial was performed in 3...
Main Authors: | Matthias Lannoo, Caroline Simoens, Roman Vangoitsenhoven, Pieter Gillard, André D’Hoore, Mieke De Vadder, Ann Mertens, Ellen Deleus, Nele Steenackers, Chantal Mathieu, Bart Van der Schueren |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2024-04-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-024-59048-w |
Similar Items
-
The prevalence of gallstone disease after sleeve gastrectomy and Roux en Y gastric bypass
by: Ramiz S. Mukhtar, et al.
Published: (2016-01-01) -
Conversion of sleeve Gastrectomy to Roux-en-Y Gastric bypass for weight loss failure
by: Mohammed Q. Abdul Jabbar, et al.
Published: (2018-04-01) -
Sleeve Gastrectomy and Roux-En-Y Gastric Bypass. Two Sculptors of the Pancreatic Islet
by: Gonzalo-Martín Pérez-Arana, et al.
Published: (2021-09-01) -
Metabolic syndrome remission after Roux-en-Y gastric bypass or sleeve gastrectomy
by: Nassour I, et al.
Published: (2017-09-01) -
EUS-directed transgastric ERCP in Roux-en-Y gastric bypass revision of sleeve gastrectomy
by: Bachir Ghandour, MD, et al.
Published: (2022-07-01)